FDA Drug recall D-1290-2020
Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured…
- FDA Drug
- Class II
- terminated
- Published 2020-06-17
On 2020-06-17 the FDA classified a Class II recall of Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured… by Lupin Pharmaceuticals, citing product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1290-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-05-28 |
| Published | 2020-06-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.
Reason
Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.
Identifiers
| ndc | 68180-512-02 |
|---|---|
| ndc | 68180-512-30 |
| ndc | 68180-512-09 |
| ndc | 68180-512-01 |
| ndc | 68180-512-03 |
| ndc | 68180-513-30 |
| ndc | 68180-513-03 |
| ndc | 68180-513-01 |
| ndc | 68180-513-09 |
| ndc | 68180-513-02 |
| ndc | 68180-513-05 |
| ndc | 68180-517-03 |
| ndc | 68180-517-01 |
| ndc | 68180-517-30 |
| ndc | 68180-517-09 |
| ndc | 68180-517-04 |
| ndc | 68180-517-02 |
| ndc | 68180-980-03 |
| ndc | 68180-980-30 |
| ndc | 68180-980-01 |
| ndc | 68180-980-09 |
| ndc | 68180-980-05 |
| ndc | 68180-980-02 |
| ndc | 68180-981-01 |
| ndc | 68180-981-03 |
| ndc | 68180-981-30 |
| ndc | 68180-981-09 |
| ndc | 68180-981-02 |
| ndc | 68180-981-05 |
| ndc | 68180-982-01 |
| ndc | 68180-982-02 |
| ndc | 68180-982-30 |
| ndc | 68180-982-03 |
| ndc | 68180-982-09 |
| ndc | 68180-979-01 |
| ndc | 68180-979-03 |
| ndc | 68180-979-30 |
| ndc | 68180-979-09 |
| ndc | 68180-514-01 |
| ndc | 68180-514-02 |
| ndc | 68180-514-03 |
| ndc | 68180-514-09 |
| ndc | 68180-514-30 |
| ndc | 68180-514-05 |
| ndc | 68180-515-01 |
| ndc | 68180-515-02 |
| ndc | 68180-515-03 |
| ndc | 68180-515-09 |
| ndc | 68180-515-30 |
| ndc | 68180-515-05 |
| ndc | 68180-516-01 |
| ndc | 68180-516-02 |
| ndc | 68180-516-03 |
| ndc | 68180-516-09 |
| ndc | 68180-516-30 |
| code_info | Lot # Q900683, Exp. 10/31/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1290-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.